Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04929899 · ClinicalTrials.gov registry record · NA
Bright Ideas - CIN Feasibility Study
A NA study of Acute Lymphoblastic Leukemia (ALL), sponsored by The Hospital for Sick Children.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 4
- Study locations
NCT04929899: Recruiting NA study of Acute Lymphoblastic Leukemia (ALL), sponsored by The Hospital for Sick Children.
NCT04929899 is a NA study of Acute Lymphoblastic Leukemia (ALL) that is actively recruiting participants, run by The Hospital for Sick Children. The registered enrollment target is 75 participants, below the 6,301-participant average among 16 other Acute Lymphoblastic Leukemia (ALL) trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04929899, a NA study of Acute Lymphoblastic Leukemia (ALL), is actively recruiting participants, sponsored by The Hospital for Sick Children.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 4
- Study locations
Study Summary
In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common treatment-related symptom.
Primary Outcome
A future trial will be feasible if * 50% of patients deemed to be eligible to participate in Phase 1 consent/assent to participate * the recruitment into Phase 2 of 20 evaluable patients across all participating centers within 24 months of study activation of whom 80% return a completed CINV diary for at least 5 days of each 7-day data collection period. A completed CINV diary contains at least one PeNAT score and a record of the time of each vomiting episode or noting the presence/absence of v
Conditions Studied
Interventions
- BEHAVIORAL Bright Ideas - CIN Training
Study Locations (4)
California
- Children's Hospital Los Angeles - Los Angeles
New Jersey
- Rutgers Cancer Institute - New Brunswick
Virginia
- Inova Children's Hospital - Falls Church
Ontario
- Hospital for Sick Children - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2025-06 |
| Phase | NA |
What NCT04929899 shows while recruiting
NCT04929899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 6,301-participant average among 16 other Acute Lymphoblastic Leukemia (ALL) trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Acute Lymphoblastic Leukemia (ALL) appearing as the primary indexed condition, and to 1 intervention - of which Bright Ideas - CIN Training is the first listed.
NCT04929899 reports a single indexed study location in California, New Jersey, Virginia.
Frequently Asked Questions
What is clinical trial NCT04929899 about?
NCT04929899 is a clinical study titled "Bright Ideas - CIN Feasibility Study". In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common tr...
What is the current status of trial NCT04929899?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2022-03-01. Estimated completion is 2025-06.
What conditions does trial NCT04929899 study?
This clinical trial studies the following conditions: Acute Lymphoblastic Leukemia (ALL).
What interventions are being tested in trial NCT04929899?
The interventions under investigation include: Bright Ideas - CIN Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04929899?
This trial is sponsored by The Hospital for Sick Children, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04929899 being conducted?
This trial has 4 study locations across California, New Jersey, Virginia, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Lymphoblastic Leukemia (ALL)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04929899's enrollment target sits among peer trials
75 4th of 16 higher than 13 of 16 other Acute Lymphoblastic Leukemia (ALL) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Lymphoblastic Leukemia (ALL) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
RECRUITING · NA
-
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
COMPLETED · NA
-
Reduce Sedentary Time in Acute Lymphoblastic Leukemia
COMPLETED · NA
-
Cord Blood Transplant in Adults With Blood Cancers
RECRUITING · Phase 2
-
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RECRUITING
-
Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI